| in €m | Note | 2024 | 2025 |
| Revenue | (H) (16) | 1,274.4 | 1,302.4 |
| Cost of sales | (H) (17) | -979.4 | -961.8 |
| Gross profit |
| 295.0 | 340.6 |
| Research and development costs | (H) (17) | -54.5 | -46.2 |
| Distribution costs | (H) (17) | -171.0 | -155.3 |
| Administrative expenses | (H) (17) | -104.0 | -106.5 |
| Other operating income | (H) (19) | 19.4 | 37.4 |
| Other operating expenses | (H) (19) | -23.7 | -38.4 |
| Impairment gains and losses on financial assets | (H) (19) | 3.3 | -0.1 |
| Other financial results | (H) (20) | 0.4 | -0.2 |
| Earnings before interest and taxes (EBIT) |
| -35.1 | 31.3 |
| Other interest and similar income |
| 4.9 | 2.9 |
| Other interest and similar expenses |
| -29.0 | -26.6 |
| Interest result | (H) (20) | -24.1 | -23.7 |
| Earnings before taxes (EBT) |
| -59.2 | 7.6 |
| Income tax expense | (H) (21) | -10.6 | -21.1 |
| Net profit |
| -69.8 | -13.5 |
| of which |
|
|
|
| ttributable to owners of the Parent |
| -70.1 | -13.5 |
| ttributable to non-controlling interests |
| 0.3 | – |
| Earnings per share (in €. basic/dilutive) | (H) (22) | -4.24 | -0.81 |
